King Street Capital is preparing to launch a new private credit fund, backed by a $70m investment from Generali Investments, the asset management division of the Italian insurance company Generali, according to a report by Bloomberg.
Private equity firms increased their activity in Europe last year, capitalising on the continent’s economic difficulties to acquire large companies at lower valuations, according to a report by the Financial Times.
Brookfield Asset Management has announced the renewal of its normal course issuer bid, allowing the repurchase of up to 37,123,295 Class A Limited Voting Shares, which represents about 10% of its public float, according to Tipranks’ Stock Screener.
Blue Owl Capital is spearheading a private credit deal worth approximately $4bn for PCI Pharma Services, which, if finalised, would rank among the largest direct lending agreements of the year, according to a report by Bloomberg citing sources familiar with the matter.
Blackstone is considering various strategic options for Liftoff, including a sale, which could value the mobile app marketing provider at over $4bn, including debt, according to a report by Reuters citing two sources familiar with the matter.
Shares of Australia’s Insignia Financial surged to a three-year high on Monday as the bidding war intensified, with Bain Capital increasing its offer to AUD 2.87bn ($1.76bn), aligning with the rival bid from CC Capital, according to a report by Reuters.
Growth equity firm Valspring Capital has closed its first fund, Valspring Capital Fund I, exceeding its $255m target, with plans to focus on investments in growth-stage companies in the healthcare sector.
Former Blackstone Executive Mustafa Siddiqui has launched SQ Capital, a newly established private equity secondaries firm, with the goal of tapping into the growing demand for liquidity in the middle-market sector, according to a report by Wall Street Journal.
Buyout firms have long relied on controversial loans backed by equity stakes to enhance fund returns, but growing investor criticism has triggered a slowdown, according to a report by Bloomberg UK.
Global healthcare private equity (PE) deal value soared to an estimated $115bn in 2024, marking the second-highest total on record. This surge was driven by an increase in the number of large deals, with five transactions surpassing $5bn, compared to two deals in 2023 and just one in 2022.
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
